Lipid Metabolism and Survival Across the Frontotemporal Dementia-Amyotrophic Lateral Sclerosis Spectrum: Relationships to Eating Behavior and Cognition

Hypothalamic atrophy is related to body mass index and age at onset in amyotrophic lateral sclerosis

(2017) Rebekah Ahmed et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria

(2017) Michael J. Strong et al.   Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Metabolic Syndrome and Cognitive Impairment: Current Epidemiology and Possible Underlying Mechanisms

(2017) Francesco Panza et al.   JOURNAL OF ALZHEIMERS DISEASE

Alterations in the hypothalamic melanocortin pathway in amyotrophic lateral sclerosis

(2016) Pauline Vercruysse et al.   BRAIN

Energy expenditure in frontotemporal dementia: a behavioural and imaging study

(2016) Rebekah M. Ahmed et al.   BRAIN

Cognition and eating behavior in amyotrophic lateral sclerosis: effect on survival

(2016) R. M. Ahmed et al.   JOURNAL OF NEUROLOGY

Neuronal network disintegration: common pathways linking neurodegenerative diseases

(2016) Rebekah M Ahmed et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Amyotrophic lateral sclerosis and frontotemporal dementia: distinct and overlapping changes in eating behaviour and metabolism

(2016) Rebekah M Ahmed et al.   LANCET NEUROLOGY

Assessment of Eating Behavior Disturbance and Associated Neural Networks in Frontotemporal Dementia

(2016) Rebekah M. Ahmed et al.   JAMA Neurology

A metabolic switch toward lipid use in glycolytic muscle is an early pathologic event in a mouse model of amyotrophic lateral sclerosis

(2015) L. Palamiuc et al.   EMBO Molecular Medicine

Eating behavior in frontotemporal dementia

(2015) Rebekah M. Ahmed et al.   NEUROLOGY

Blood Cell Palmitoleate-Palmitate Ratio Is an Independent Prognostic Factor for Amyotrophic Lateral Sclerosis

(2015) Alexandre Henriques et al.   PLoS One

Glycosphingolipids are modulators of disease pathogenesis in amyotrophic lateral sclerosis

(2015) James C. Dodge et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Effect of Presymptomatic Body Mass Index and Consumption of Fat and Alcohol on Amyotrophic Lateral Sclerosis

(2015) Mark H. B. Huisman et al.   JAMA Neurology

Estimating daily energy expenditure in individuals with amyotrophic lateral sclerosis

(2014) Edward J Kasarskis et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Anatomical correlates of reward-seeking behaviours in behavioural variant frontotemporal dementia

(2014) David C. Perry et al.   BRAIN

A plural role for lipids in motor neuron diseases: energy, signaling and structure

(2014) Florent Schmitt et al.   Frontiers in Cellular Neuroscience

Quantifying the Eating Abnormalities in Frontotemporal Dementia

(2014) Rebekah M. Ahmed et al.   JAMA Neurology

TDP-43 pathology in the basal forebrain and hypothalamus of patients with amyotrophic lateral sclerosis

(2014) Matthew D Cykowski et al.   Acta Neuropathologica Communications

Mitochondrial dysfunction in amyotrophic lateral sclerosis - a valid pharmacological target?

(2013) H Muyderman et al.   BRITISH JOURNAL OF PHARMACOLOGY

Hypolipidemia in Patients with Amyotrophic Lateral Sclerosis: A Possible Gender Difference?

(2013) Ji Won Yang et al.   Journal of Clinical Neurology

Neuropsychiatric changes precede classic motor symptoms in ALS and do not affect survival

(2013) E. Mioshi et al.   NEUROLOGY

Cortical atrophy in ALS is critically associated with neuropsychiatric and cognitive changes

(2013) E. Mioshi et al.   NEUROLOGY

Body mass index (BMI) as predictor of ALSFRS-R score decline in ALS patients

(2013) Ronit Reich-Slotky et al.   Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Amyotrophic lateral sclerosis and frontotemporal dementia: A behavioural and cognitive continuum

(2012) Patricia Lillo et al.   Amyotrophic Lateral Sclerosis

Relationships between Disease Progression and Serum Levels of Lipid, Urate, Creatinine and Ferritin in Japanese Patients with Amyotrophic Lateral Sclerosis: A Cross-Sectional Study

(2012) Ken Ikeda et al.   INTERNAL MEDICINE

Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia

(2011) Katya Rascovsky et al.   BRAIN

EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS) - revised report of an EFNS task force

(2011) et al.   EUROPEAN JOURNAL OF NEUROLOGY

Beneficial vascular risk profile is associated with amyotrophic lateral sclerosis

(2011) N. A. Sutedja et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Metabolic-cognitive syndrome: A cross-talk between metabolic syndrome and Alzheimer's disease

(2010) Vincenza Frisardi et al.   AGEING RESEARCH REVIEWS

How common are behavioural changes in amyotrophic lateral sclerosis?

(2010) Patricia Lillo et al.   Amyotrophic Lateral Sclerosis

Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis

(2010) J. Dorst et al.   JOURNAL OF NEUROLOGY

Energy metabolism in amyotrophic lateral sclerosis

(2010) Luc Dupuis et al.   LANCET NEUROLOGY

Amyotrophic Lateral Sclerosis-Like Conditions in Possible Association with Cholesterol-Lowering Drugs

(2009) Beatrice A. Golomb et al.   DRUG SAFETY

Lower serum lipid levels are related to respiratory impairment in patients with ALS

(2009) A. Chio et al.   NEUROLOGY

The syndromes of frontotemporal dysfunction in amyotrophic lateral sclerosis

(2008) Michael J. Strong   Amyotrophic Lateral Sclerosis

Frontal Paralimbic Network Atrophy in Very Mild Behavioral Variant Frontotemporal Dementia

(2008) William W. Seeley et al.   ARCHIVES OF NEUROLOGY

Dyslipidemia is a protective factor in amyotrophic lateral sclerosis

(2008) L. Dupuis et al.   NEUROLOGY

Use of statins and incidence of dementia and cognitive impairment without dementia in a cohort study

(2008) C. Cramer et al.   NEUROLOGY

An evaluation of a data mining signal for amyotrophic lateral sclerosis and statins detected in FDA's spontaneous adverse event reporting system

(2008) Eric Colman et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

The utility of the Cambridge Behavioural Inventory in neurodegenerative disease

(2007) C Wedderburn et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY